SEC 13F Intelligence

Propel Bio Management, LLC / KYMR

Propel Bio Management, LLC’s Kymera Therapeutics Inc Position

Does Propel Bio Management, LLC own Kymera Therapeutics Inc (KYMR)? Not currently — the last reported position was 56.4K shares worth $2M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2024
Shares
56.4K
% of Portfolio
+2.25%
Quarters Held
5
position exited

Position History KYMR

Reported value by quarter
Q4 ’23: $1MQ4 ’23Q1 ’24: $2MQ1 ’24Q2 ’24: $2MQ2 ’24Q3 ’24: $3MQ3 ’24Q4 ’24: $2MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202456.4K$2M+2.25%
Q3 202456.4K$3M+1.55%
Q2 202456.4K$2M+1.09%
Q1 202456.4K$2M+1.32%
Q4 202356.4K$1M+1.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of KYMR.